This MedLibrary.org supplementary page on Lester Crawford is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
Lester Mills Crawford (born March 13, 1938) is a former Commissioner of the United States Food and Drug Administration (FDA). Dr. Crawford resigned from the FDA in September, 2005, two months after his approval by the United States Senate. On October 17, 2006, he pleaded guilty to conflict of interest and false reporting of information about stocks he owned in food, beverage and medical device companies he was in charge of regulating."[1]
Contents |
Education
Crawford received a Doctor of Veterinary Medicine (DVM) degree from Auburn University in 1963 and a Ph.D. in pharmacology from the University of Georgia in 1969.
Personal
Crawford has been married since 1963 to Catherine Walker of Birmingham, Alabama. They have two daughters, Leigh and Mary, and four grandchildren.
Career
Prior to becoming FDA Commissioner, Crawford had served as Deputy Commissioner of FDA since February 25, 2002. From 1997-2002, he was Director of the Center for Food and Nutrition Policy at Georgetown University and at Virginia Tech, where it moved to in 2001.
Crawford also served as Administrator of the Food Safety and Inspection Service (United States Department of Agriculture) from 1987 to 1991 as well as director of the FDA's Center for Veterinary Medicine from 1978 to 1980, and again from 1982 to 1985. Previously in his career he was chair of the Department of Physiology-Pharmacology at the University of Georgia, executive director of the Association of American Veterinary Medical Colleges, and a practicing veterinarian.
FDA appointment
Nomination
On February 15, 2005, Crawford was nominated by President George W. Bush to head the FDA, pending U.S. Senate confirmation.
His nomination stalled for two months after he was accused of an extramarital affair with an FDA employee. An investigation by the Department of Health and Human Services inspector general found no evidence of an affair. On April 28, 2006 it was announced that he was being investigated by a grand jury over accusations of financial improprieties and false statements to Congress.[2][3]
Senate approval
The Senate Health Committee approved the nomination on June 15, and Crawford was approved by the Senate on July 18.
Short-lived, Controversial FDA Career
Crawford resigned on September 23 in a surprise announcement. His appointment was embattled from the beginning as several senators had threatened to place holds on his confirmation vote until the FDA made a decision on whether or not to allow over-the-counter sales of the "Plan B" or "Morning-after" emergency contraception pills.
The White House nominated Andrew von Eschenbach to succeed Crawford as commissioner.
Justice Department charges
On October 16, 2006, the US Justice Department formally charged Crawford with lying and violating conflict-of-interest laws for falsely reporting his ownership of stock in companies regulated by the FDA.[4]. Specifically, according to the charging documents, he falsely stated in a 2004 government filing that shares of Sysco Corp. and Kimberly-Clark Corp. had been sold when he and his wife continued to hold them, and also failed to disclose income from exercising stock options in Embrex Inc.[5] He pleaded guilty the next day.[1]
On February 27, 2007, was sentenced to three years' supervised probation and fines of roughly $90,000.[6]
Later lobbying career
Crawford followed his position at the FDA by joining a Washington lobbying firm, Policy Directions Inc.
References
- ^ a b Andrew Bridges (October 17, 2006). "Ex-FDA Chief Pleads Guilty in Stock Case", The Associated Press.
- ^ Ex-Head of F.D.A. Faces Criminal Inquiry, by Gardner Harris, The New York Times, April 28, 2006, published April 29, 2006
- ^ Grand Jury Is Investigating Ex-Chief of FDA, Associated Press, Sunday, April 30, 2006; Page A07
- ^ Stephanie Saul (October 17, 2006). "Ex-F.D.A. Chief Is Charged With Conflict", New York Times.
- ^ Cary O'Reilly (October 16, 2006). "Crawford, Ex-U.S. Drug Regulator, Faces Stock Charges (Update2)", Bloomberg.
- ^ Hope Yen (February 27, 2007). "Ex-FDA chief sentenced to probation in stock scandal", Associated Press.
External links
- HHS press release for Crawford being named FDA Deputy Commissioner
- Official FDA biography
- Matthew Herper Former FDA Chief Dr. Crawford Denies Financial Conflicts, Forbes, September. 28, 2005.
- Documents raise questions about decision on morning-after pill, Tony Pugh, Knight Ridder Newspapers, March 9, 2006
- Lester Crawford's federal campaign contributions
Wikipedia content modification information:
- This page was last modified on 3 June 2008, at 05:17.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Lester Crawford".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.